Amisulpride is an “atypical” antipsychotic associated with low weight gain

Author： Leucht Stefan Wagenpfeil Stefan Hamann Johannes Kissling Werner

ISSN： 0033-3158

Source： Psychopharmacology, Vol.173, Iss.1-2, 2004-04, pp. : 112-115

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Pharmacological Management of Atypical Antipsychotic-Induced Weight Gain

By Baptista Trino

CNS Drugs, Vol. 22, Iss. 6, 2008-01 ,pp. : 477-495

Adis International

Access to resources Recommend Favorite

Weight Gain Associated with Atypical Antipsychotic Use in Children and Adolescents: Prevalence, Clinical Relevance, and Management

By Stigler K.A.

Pediatric Drugs, Vol. 6, Iss. 1, 2004-01 ,pp. : 33-44

Adis International

Access to resources Recommend Favorite

Antipsychotic-associated weight gain: genetic link identified

Reactions Weekly, Vol. 1, Iss. 1413, 2012-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Atypical Antipsychotic-Induced Weight Gain: Insights into Mechanisms of Action

By Roerig James L. Steffen Kristine J. Mitchell James E.

CNS Drugs, Vol. 25, Iss. 12, 2011-12 ,pp. : 1035-1059

Adis International

Access to resources Recommend Favorite

Pharmacogenetics of leptin in antipsychotic-associated weight gain and obesity-related complications

By Lee Amy K Bishop Jeffrey R

Pharmacogenomics, Vol. 12, Iss. 7, 2011-07 ,pp. : 999-1016

Future Medicine

Access to resources Recommend Favorite